Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2014 Jan;15(1):5-6.
doi: 10.1002/embr.201338224.

The many faces of mitophagy

Affiliations
Comment

The many faces of mitophagy

Rachael M Ivatt et al. EMBO Rep. 2014 Jan.

Abstract

Failure to maintain mitochondrial integrity is linked to age‐related conditions, such as neurodegeneration. Two genes linked to Parkinson's disease, PINK1 and Parkin, play a key role in targeting the degradation of dysfunctional mitochondria (mitophagy). However, the mechanisms regulating the PINK1/Parkin pathway and other processes that impinge on mitochondrial turnover are poorly understood. Two articles in EMBO reports, by the Przedborski and Ganley groups, shed light on a new role for processed, cytoplasmic PINK1, and show that depletion of cellular iron levels stimulates PINK1/Parkin‐independent mitophagy.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Effects of PINK1 cleavage and low iron on mitophagy
In ‘healthy’ mitochondria with high membrane potential (ΔΨm), PINK1 is imported cleaved by PARL and other proteases, and processed PINK152 released into the cytosol. Upon mitochondrial damage and loss of ΔΨm, induced in vitro by CCCP or valinomycin, full-length PINK163 is stabilized on the outer surface and stimulates the recruitment of Parkin, leading to mitophagy. Przedborski and colleagues present evidence that cytoplasmic PINK152 can inhibit Parkin recruitment. A chemical screen by Ganley and colleagues found that depletion of cellular iron can trigger mitophagy in a new mechanism that does not require PINK1 or Parkin, or the loss of ΔΨm.

Comment on

References

    1. Fedorowicz MA, et al. EMBO Rep. 2013;15:86–93. - PMC - PubMed
    1. Allen GF, et al. EMBO Rep. 2013;14:1127–1135. - PMC - PubMed
    1. Deas E, et al. Hum Mol Genet. 2011;20:867–879. - PMC - PubMed
    1. Haque ME, et al. Proc Natl Acad Sci USA. 2008;105:1716–1721. - PMC - PubMed
    1. Dagda RK, et al. J Neurochem. 2013 doi: 10.1111/jnc.12494. - DOI

LinkOut - more resources